Provided are: a pharmaceutical composition comprising a lyophilized glycolytic enzyme having an excellent titer; and a package that comprises said pharmaceutical composition. This pharmaceutical composition is a unit dose formulation which comprises a lyophilized glycolytic enzyme having a titer of at least 0.3 unit/µg as an active ingredient, and which contains the glycolytic enzyme in an amount of 2-8 µg.